Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aldeyra Therapeutics, Inc.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non-infectious anterior uveitis
Grade 1 - Grade 3 anterior chamber cell count
Subjects must have Intraocular pressure \<25 mmHg at baseline and may only administer a maximum of 1 topical medication to control Intraocular pressure in the study eye.
Visual acuity ≥ 20/200 in the study eye
You may not be if
Severe/serious ocular pathology
Active intermediate or posterior uveitis.
Previous anterior uveitis episode in the study eye within 4 weeks of Visit 1
Oral corticosteroids within 14 days of Visit 1
Intravitreal or sub-Tenon corticosteroid treatment in the study eye within the past 6 months.
Clareo Health | A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
